Rabigen SAG2

Negara: Uni Eropa

Bahasa: Inggris

Sumber: EMA (European Medicines Agency)

Beli Sekarang

Selebaran informasi Selebaran informasi (PIL)
06-11-2018
Karakteristik produk Karakteristik produk (SPC)
06-11-2018

Bahan aktif:

live attenuated rabies virus, SAG2 strain

Tersedia dari:

Virbac S.A.

Kode ATC:

QI07AA02

INN (Nama Internasional):

live vaccine against rabies

Kelompok Terapi:

Raccoon dogs (Nyctereutes procyonoides); Red foxes (Vulpes vulpes)

Area terapi:

Live viral vaccines

Indikasi Terapi:

For the active immunisation of red foxes and raccoon dogs to prevent infection by rabies virus.The duration of protection is of at least 6 months.

Ringkasan produk:

Revision: 9

Status otorisasi:

Authorised

Tanggal Otorisasi:

2000-04-06

Selebaran informasi

                                11
-
20 baits per square km over the areas where fox / raccoon dog density
indexes were more than 3
foxes / raccoon dogs seen per 10 km.
Read the package leaflet before use.
8.
SPECIAL WARNINGS, IF NECESSARY
It is recommended to wear rubber gloves.
People handling and distributing this vaccine should be vaccinated
against rabies.
Immunocompromised/immunosuppressed individuals must not be allowed to
handle this vaccine.
In the event of human exposure to the active ingredient of the
vaccine, seek medical advice
immediately and show the package leaflet i or the label to the
physician.
No adverse events have been reported in the target species.
As this vaccine presentation contains traces of gentamicin and
contains tetracycline as biomarker,
occasional hypersensitivity reactions may be observed in domestic
animals that have accidentally
ingested the bait.
Vomiting due to gastric intolerance (potentially due to the
aluminium/PVC sachet as part of the bait
vaccine), in dogs which have accidentally ingested the bait, has been
reported.
9.
EXPIRY DATE
EXP : {month/year}
10.
SPECIAL STORAGE CONDITIONS
Store in a freezer at -40°C to -20°C.
Protect from light. Keep the boxes tightly closed.
11.
SPECIAL PRECAUTIONS FOR THE DISPOSAL OF UNUSED PRODUCTS OR
WASTE MATERIALS, IF ANY
Dispose of waste material and any unplaced baits at the end of the day
of distribution by boiling or
incineration or immersion in an appropriate disinfectant approved for
use by the competent authorities.
12.
THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR
RESTRICTIONS REGARDING SUPPLY AND USE, IF APPLICABLE
For animal treatment only - to be supplied only on veterinary
prescription.
Restricted to duly designated competent administrative authorities.
The import, sale, supply and/or use of this veterinary medicinal
product is or may be prohibited in
certain
Member
States
on
the
whole
or
part
of
their
territory,
see
package
insert
for
further
information.
13.
THE WORDS “KEEP OUT OF THE REACH AND SIGHT OF CHILDREN”
Keep out of the reach a
                                
                                Baca dokumen lengkapnya
                                
                            

Karakteristik produk

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Rabigen SAG2 oral suspension, for red foxes and raccoon dogs.
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE :
Live attenuated rabies virus, SAG2 strain
minimum 8 log10 CCID50*/dose
* CCID50 : Cell Culture Infective Dose 50%
EXCIPIENTS :
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral suspension
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Red foxes (_Vulpes vulpes_) and raccoon dogs (_Nyctereutes
procyonoides_).
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the active immunisation of red foxes and raccoon dogs to prevent
infection by rabies virus.
The duration of protection is of at least 6 months.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Not applicable.
4.5
SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Baits shall not be distributed in inhabited areas, roads and watery
areas.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO
ANIMALS
It is recommended to wear rubber gloves.
People handling and distributing this vaccine should be vaccinated
against rabies.
Immunocompromised/immunosuppressed individuals must not be allowed to
handle this vaccine.
In the event of human exposure to the active ingredient of the
vaccine, seek medical advice
immediately and show the package leaflet or the label to the
physician.
3
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
No adverse events have been reported in the target species.
As this vaccine presentation contains traces of gentamicin and
contains tetracycline as biomarker,
occasional hypersensitivity reactions may be observed in domestic
animals that have accidentally
ingested the bait.
Vomiting due to gastric intolerance (potentially due to the
aluminium/PVC sachet as part of the bait
vaccine), in dogs which have accidentally ingested the bait, has been
reported.
4.7
USE DURING PREGNANCY, LACTATION OR LAY
The safety of the vaccine in
                                
                                Baca dokumen lengkapnya
                                
                            

Dokumen dalam bahasa lain

Selebaran informasi Selebaran informasi Bulgar 06-11-2018
Karakteristik produk Karakteristik produk Bulgar 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Bulgar 21-07-2013
Selebaran informasi Selebaran informasi Spanyol 06-11-2018
Karakteristik produk Karakteristik produk Spanyol 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Spanyol 21-07-2013
Selebaran informasi Selebaran informasi Cheska 06-11-2018
Karakteristik produk Karakteristik produk Cheska 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Cheska 21-07-2013
Selebaran informasi Selebaran informasi Dansk 06-11-2018
Karakteristik produk Karakteristik produk Dansk 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Dansk 21-07-2013
Selebaran informasi Selebaran informasi Jerman 06-11-2018
Karakteristik produk Karakteristik produk Jerman 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Jerman 21-07-2013
Selebaran informasi Selebaran informasi Esti 06-11-2018
Karakteristik produk Karakteristik produk Esti 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Esti 21-07-2013
Selebaran informasi Selebaran informasi Yunani 06-11-2018
Karakteristik produk Karakteristik produk Yunani 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Yunani 21-07-2013
Selebaran informasi Selebaran informasi Prancis 06-11-2018
Karakteristik produk Karakteristik produk Prancis 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Prancis 21-07-2013
Selebaran informasi Selebaran informasi Italia 06-11-2018
Karakteristik produk Karakteristik produk Italia 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Italia 21-07-2013
Selebaran informasi Selebaran informasi Latvi 06-11-2018
Karakteristik produk Karakteristik produk Latvi 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Latvi 21-07-2013
Selebaran informasi Selebaran informasi Lituavi 06-11-2018
Karakteristik produk Karakteristik produk Lituavi 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Lituavi 21-07-2013
Selebaran informasi Selebaran informasi Hungaria 06-11-2018
Karakteristik produk Karakteristik produk Hungaria 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Hungaria 21-07-2013
Selebaran informasi Selebaran informasi Malta 06-11-2018
Karakteristik produk Karakteristik produk Malta 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Malta 21-07-2013
Selebaran informasi Selebaran informasi Belanda 06-11-2018
Karakteristik produk Karakteristik produk Belanda 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Belanda 21-07-2013
Selebaran informasi Selebaran informasi Polski 06-11-2018
Karakteristik produk Karakteristik produk Polski 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Polski 21-07-2013
Selebaran informasi Selebaran informasi Portugis 06-11-2018
Karakteristik produk Karakteristik produk Portugis 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Portugis 21-07-2013
Selebaran informasi Selebaran informasi Rumania 06-11-2018
Karakteristik produk Karakteristik produk Rumania 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Rumania 21-07-2013
Selebaran informasi Selebaran informasi Slovak 06-11-2018
Karakteristik produk Karakteristik produk Slovak 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Slovak 21-07-2013
Selebaran informasi Selebaran informasi Sloven 06-11-2018
Karakteristik produk Karakteristik produk Sloven 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Sloven 21-07-2013
Selebaran informasi Selebaran informasi Suomi 06-11-2018
Karakteristik produk Karakteristik produk Suomi 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Suomi 21-07-2013
Selebaran informasi Selebaran informasi Swedia 06-11-2018
Karakteristik produk Karakteristik produk Swedia 06-11-2018
Laporan Penilaian publik Laporan Penilaian publik Swedia 21-07-2013
Selebaran informasi Selebaran informasi Norwegia 06-11-2018
Karakteristik produk Karakteristik produk Norwegia 06-11-2018
Selebaran informasi Selebaran informasi Islandia 06-11-2018
Karakteristik produk Karakteristik produk Islandia 06-11-2018
Selebaran informasi Selebaran informasi Kroasia 06-11-2018
Karakteristik produk Karakteristik produk Kroasia 06-11-2018

Lihat riwayat dokumen